These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23584888)

  • 1. Asymmetric dimethylarginine predicts survival in the elderly.
    Pizzarelli F; Maas R; Dattolo P; Tripepi G; Michelassi S; D'Arrigo G; Mieth M; Bandinelli S; Ferrucci L; Zoccali C
    Age (Dordr); 2013 Dec; 35(6):2465-75. PubMed ID: 23584888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
    Böger RH; Sullivan LM; Schwedhelm E; Wang TJ; Maas R; Benjamin EJ; Schulze F; Xanthakis V; Benndorf RA; Vasan RS
    Circulation; 2009 Mar; 119(12):1592-600. PubMed ID: 19289633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
    Lu TM; Chung MY; Lin MW; Hsu CP; Lin SJ
    Int J Cardiol; 2011 Dec; 153(2):135-40. PubMed ID: 21794936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
    Tripepi G; Mattace Raso F; Sijbrands E; Seck MS; Maas R; Boger R; Witteman J; Rapisarda F; Malatino L; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1714-21. PubMed ID: 21642364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
    Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
    Anderssohn M; Rosenberg M; Schwedhelm E; Zugck C; Lutz M; Lüneburg N; Frey N; Böger RH
    J Card Fail; 2012 Dec; 18(12):904-11. PubMed ID: 23207078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ADMA, urinary ADMA excretion, and late mortality in renal transplant recipients.
    Said MY; Bollenbach A; Minović I; van Londen M; Frenay AR; de Borst MH; van den Berg E; Kayacelebi AA; Tsikas D; van Goor H; Navis G; Bakker SJL
    Amino Acids; 2019 Jun; 51(6):913-927. PubMed ID: 30915571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
    Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
    Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study.
    Gore MO; Lüneburg N; Schwedhelm E; Ayers CR; Anderssohn M; Khera A; Atzler D; de Lemos JA; Grant PJ; McGuire DK; Böger RH
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2682-8. PubMed ID: 24008162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.
    Zhou S; Zhu Q; Li X; Chen C; Liu J; Ye Y; Ruan Y; Hei Z
    Sci Rep; 2017 Mar; 7():44692. PubMed ID: 28294182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.
    Visser M; Vermeulen MA; Richir MC; Teerlink T; Houdijk AP; Kostense PJ; Wisselink W; de Mol BA; van Leeuwen PA; Oudemans-van Straaten HM
    Br J Nutr; 2012 May; 107(10):1458-65. PubMed ID: 22129964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort.
    Lüneburg N; Xanthakis V; Schwedhelm E; Sullivan LM; Maas R; Anderssohn M; Riederer U; Glazer NL; Vasan RS; Böger RH
    J Nutr; 2011 Dec; 141(12):2186-90. PubMed ID: 22031661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
    Atzler D; Schwedhelm E; Nauck M; Ittermann T; Böger RH; Friedrich N
    Clin Chem Lab Med; 2014 Dec; 52(12):1835-42. PubMed ID: 24945429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities.
    Sydow K; Fortmann SP; Fair JM; Varady A; Hlatky MA; Go AS; Iribarren C; Tsao PS;
    Clin Chem; 2010 Jan; 56(1):111-20. PubMed ID: 19892843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
    Leong T; Zylberstein D; Graham I; Lissner L; Ward D; Fogarty J; Bengtsson C; Björkelund C; Thelle D;
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):961-7. PubMed ID: 18292394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.